{"id":"W4391613321","doi":"10.1016/j.jaip.2023.12.008","title":"Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”","year":2024,"lang":"en","type":"letter","venue":"The Journal of Allergy and Clinical Immunology In Practice","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta; University of British Columbia","funders":"Genentech; Grifols; Glenmark Pharmaceuticals; Sanofi Genzyme; Incyte; Cerecor; Covis Pharma; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Efficacy and Mechanism Evaluation Programme; Optimum Patient Care; Health Technology Assessment Programme; Sanofi; AstraZeneca; Amgen; AKL Research and Development; Pfizer; GlaxoSmithKline","keywords":"Medicine; Asthma; Guideline; Allergy; Scopus; Omalizumab; Pediatrics; Inhaled corticosteroids; Intensive care medicine; MEDLINE; Internal medicine; Immunology; Pathology; Immunoglobulin E","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005587946,0.0007392281,0.001399427,0.001036211,0.003335883,0.003181624,0.00196637,0.04109848,0.003791328],"category_scores_gemma":[0.02975062,0.0009582549,0.001265737,0.001381409,0.001834561,0.002746193,0.001799109,0.03487719,0.004722641],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002956316,"about_ca_system_score_gemma":0.006185678,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01478708,"about_ca_topic_score_gemma":0.02262981,"domain_scores_codex":[0.9958475,0.001343601,0.0007734915,0.0005383802,0.0007602457,0.0007366861],"domain_scores_gemma":[0.9845057,0.008887979,0.001519507,0.0004722072,0.002473007,0.00214154],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000084578,0.00003226975,0.00373508,0.00005349016,0.00003936038,0.0008689138,0.0002493077,0.00004199423,0.0001094176,0.0007922211,0.989992,0.004001447],"study_design_scores_gemma":[0.0002726935,0.0001615377,0.01596102,0.0008529606,0.000165699,0.00172781,0.002134208,0.0006438604,0.0004283898,0.004645932,0.972806,0.0001999108],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0007227841,0.0005058427,0.00005143726,0.9862067,0.01132203,0.00001042872,0.000256027,0.00001894508,0.0009059209],"genre_scores_gemma":[0.002326269,0.00035112,0.00009589169,0.9842454,0.01078632,0.00003511436,0.00007444956,0.0000126929,0.002072785],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.04109848,"threshold_uncertainty_score":0.02955228,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03754145150342928,"score_gpt":0.3355170644046436,"score_spread":0.2979756129012143,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}